Published on 07/05/2026
Case Study on Managing ERES Data Integrity Risks in Contract Manufacturing Organizations
In the realm of pharmaceutical manufacturing, the use of electronic records and electronic signatures (ERES) has become integral to compliance and operational efficiency. However, these systems are not without their risks, particularly in contract manufacturing organizations (CMOs) where compliance with regulations such as 21 CFR Part 11 and EU Annex 11 is critical. This article presents a case study of a CMO that encountered a significant data integrity issue, highlighting the steps taken from detection to corrective actions.
By exploring this scenario, readers will gain actionable insights into identifying symptoms, investigating root causes, and implementing an effective CAPA strategy to mitigate ERES-related risks. The goal is to enhance understanding and compliance in the increasingly digital landscape of pharmaceutical manufacturing.
Symptoms/Signals on the Floor or in the Lab
In early March 2023, a CMO was alerted to discrepancies in electronic batch records (EBRs) during routine internal audits. The quality control (QC) team noticed that the recorded temperatures for critical storage conditions did not align
Additional signals indicating potential data integrity issues included:
- Inconsistent data entries across multiple batches.
- Unusual patterns of user access and modifications to sensitive records.
- Lack of adequate audit trails for changes made to crucial electronic documents.
The QC manager reported these anomalies to the quality assurance (QA) department, and an urgent investigation was initiated, emphasizing the need for immediate containment to prevent potential release of non-compliant products.
Likely Causes
To effectively address the data integrity issue, it’s essential to categorize the likely causes into the following categories: Materials, Method, Machine, Man, Measurement, and Environment. Understanding these root causes can facilitate a comprehensive investigation.
| Category | Likely Cause |
|---|---|
| Materials | Improper handling and storage of recording devices led to data loss. |
| Method | Inadequate training on the electronic record system led to erroneous data entries. |
| Machine | Malfunction of the environmental monitoring system (EMS) resulted in erroneous readings. |
| Man | User error due to lack of familiarity with data entry protocols. |
| Measurement | Compounded errors in manual data transcription into electronic systems. |
| Environment | Fluctuating humidity levels affected sensor accuracy. |
Immediate Containment Actions (first 60 minutes)
Upon recognizing the issue, the QA team took prompt containment actions to mitigate any risks associated with product quality and compliance. The immediate steps included:
- Ceasing all production related to affected batches to prevent further integrity violations.
- Isolating and restricting access to the EBR system to ensure no additional entries or modifications could occur.
- Notifying regulatory authorities as stipulated by the company’s incident management SOPs.
- Engaging IT support to investigate the EBR system for any anomalies or unauthorized access.
- Conducting a preliminary review of recent audit trails for quick identification of potential user errors.
These initial actions were a crucial step toward maintaining compliance and securing data integrity before the onset of a detailed investigation.
Investigation Workflow (data to collect + how to interpret)
The investigation workflow was methodical and emphasized the need for comprehensive data collection and interpretation:
- Data Collection: All relevant electronic records, including batch records, sensor data, and user access logs were collected. The QC team also gathered historical data relating to the affected batches and documentation of any previous deviations.
- Interviews: The QA team conducted interviews with personnel involved in the data entry and handling process to ascertain training levels and adherence to SOPs.
- Audit Trail Review: Detailed examination of the EBR audit trails was performed to understand the timeline and source of discrepancies. This included cross-referencing timestamps and user IDs with physical observations.
Interpretation of collected data focused on correlating user actions with documented irregularities, identifying trends indicative of training lapses or procedural non-compliance, and assessing the robustness of both the EMS and EBR systems.
Root Cause Tools (5-Why, Fishbone, Fault Tree) and when to use which
Several root cause analysis tools were employed during the investigation, each chosen based on the complexity and nature of the identified issues:
- 5-Why Analysis: This technique was utilized for straightforward issues such as why certain data were improperly entered. By asking “why” repeatedly, the team uncovered inadequate training as a significant underlying cause.
- Fishbone Diagram: For a broader overview of potential causes affecting various aspects, the Fishbone diagram was drawn to categorize different factors (personnel, procedures, machines, etc.) and visually map out areas requiring deeper examination.
- Fault Tree Analysis: For complex interactions between equipment and processes, a fault tree analysis helped trace back failures in the EMS and data handling that led to the discrepancies observed.
Each of these tools offered unique insights that, when combined, provided a comprehensive view of the root causes behind the integrity failures.
CAPA Strategy (correction, corrective action, preventive action)
Once root causes were identified, the CMO implemented a robust CAPA strategy focusing on three core components:
- Correction: Immediate correction involved the rescission of invalid batch records and proper documentation of discrepancies to ensure traceability and transparency.
- Corrective Action: A thorough revision of training programs and the development of a targeted retraining schedule for all personnel involved in data entry were crucial. Additionally, system checks were implemented that necessitated dual approvals for significant entries or changes.
- Preventive Action: The environmental monitoring system was upgraded, and routine verifications were instituted. Enhanced monitoring of data access and modification through better IT support and scheduled audits were also established.
This comprehensive CAPA plan not only addressed the immediate issues but also laid the groundwork for preventing future breaches in data integrity.
Related Reads
- Mastering Good Documentation Practices (GDP/ALCOA+) in Pharmaceuticals
- Ensuring Compliance with Electronic Records and Electronic Signatures (ERES) in Pharma
Control Strategy & Monitoring (SPC/trending, sampling, alarms, verification)
With the CAPA actions in place, the CMO recognized the necessity of a robust control strategy and ongoing monitoring mechanisms to ensure the sustainability of improvements. Key components included:
- Statistical Process Control (SPC): Implementation of SPC charts for environmental monitoring data allowed for real-time detection of deviations from expected parameters.
- Regular Sampling: Scheduled sampling of electronic records was established to ensure continuous compliance with established data integrity protocols.
- Alert Systems: Automated alarms were designed to notify personnel of critical deviations in environmental conditions or access irregularities within EBRs.
- Verification Processes: Processes to ensure that corrective actions were effective were consistently documented and reviewed, reinforcing a culture of quality assurance across the organization.
This proactive plan not only maintained compliance but also fostered a greater culture of data integrity awareness among employees.
Validation / Re-qualification / Change Control impact (when needed)
As part of the overhaul following the incident, the CMO also had to address validation and change control aspects of its systems. The following steps were undertaken:
- System Validation: Validation of the updated electronic records system involved revisiting the entire validation lifecycle to ensure all aspects of the software were compliant with 21 CFR Part 11 and EU Annex 11.
- Re-qualification: The environmental monitoring system’s sensors were subjected to a rigorous re-qualification process to verify their performance and reliability following the incident.
- Change Control Procedures: Strengthening change control procedures was vital for documenting any modifications to software or hardware, ensuring all changes were justified and properly reviewed.
These measures ensured that the systems in place were not only compliant but also robust against future threats to data integrity.
Inspection Readiness: What Evidence to Show
Preparation for regulatory inspections, particularly following a significant incident, required meticulous attention to detail. Key elements of readiness included:
- Documentation: All records of the incident, including audit trails, CAPA activities, training logs, and communications with regulatory authorities, were gathered and organized systematically.
- Procedural SOPs: Updated SOPs reflecting new training protocols and procedures for electronic records management were prepared for review.
- Evidence of CAPA Implementation: Demonstration of completed corrective actions through documentation that showed retraining sessions, system upgrades, and monitoring changes were in effect.
- Audit Observations: Summaries of any recent internal audits with corrective actions taken based on observations and findings were included for transparency.
This comprehensive approach to inspection readiness mitigated risks and demonstrated the CMO’s commitment to regulatory compliance and data integrity.
FAQs
What are electronic records and electronic signatures (ERES)?
ERES refer to digital documents and authentication mechanisms used to verify the authenticity of electronic records in compliance with regulatory standards like 21 CFR Part 11 and EU Annex 11.
Why is data integrity critical in pharmaceutical manufacturing?
Data integrity is crucial as it ensures the accuracy and reliability of information used in decision-making, ultimately impacting product quality and patient safety.
What steps can be taken to prevent electronic record discrepancies?
Preventive measures include regular training for staff, implementing stringent access controls, and routine audits of electronic systems.
How often should electronic record systems be validated?
Electronic record systems should be validated regularly, particularly upon significant changes or upgrades, to ensure ongoing compliance and functionality.
What are the consequences of data integrity violations?
Consequences may include regulatory penalties, product recalls, reputational damage, and potential legal ramifications.
How can I enhance my organization’s compliance culture?
Fostering a compliance culture involves continuous training, promoting open communication about compliance issues, and providing resources to support proper practices.
What audits should be implemented for ERES compliance?
Regular compliance audits, internal and external, should be conducted focusing on ERES processes, user access, and system functionality.
How is SPC used in monitoring electronic records?
SPC techniques track process variations and identify trends, ensuring that electronic records remain within validated parameters and compliance is maintained.